Astrana Health, Inc. (ASTH) – What Are Investment Firms Thinking About This Stock?

Astrana Health, Inc. (NASDAQ:ASTH) has been assigned a consensus rating of “Moderate Buy” from the ten analysts that are presently covering the stock, MarketBeat.com reports. Two equities research analysts have rated the stock with a hold recommendation and eight have issued a buy recommendation on the company. The average twelve-month price objective among brokerages that have covered the stock in the last year is $50.38.

A number of analysts have recently commented on the stock. Barclays lifted their price target on shares of Astrana Health from $50.00 to $53.00 and gave the stock an “overweight” rating in a research note on Friday, August 7th. TD Cowen increased their price objective on shares of Astrana Health from $45.00 to $50.00 and gave the company a “buy” rating in a research report on Tuesday, July 14th. BTIG Research lifted their target price on shares of Astrana Health from $50.00 to $65.00 and gave the stock a “buy” rating in a research report on Tuesday, July 14th. Oppenheimer began coverage on shares of Astrana Health in a research report on Tuesday, September 15th. They issued an “outperform” rating and a $53.00 target price for the company. Finally, Truist Financial boosted their target price on shares of Astrana Health from $47.00 to $55.00 and gave the company a “buy” rating in a research note on Monday, August 10th.

Astrana Health News Roundup

Here are the key news stories impacting Astrana Health this week:

• Positive Sentiment: Needham raised its price target from $41 to $45 and reiterated a Buy rating, implying about 31% upside from the cited $34.38 share price. Needham rating information
• Positive Sentiment: Third-quarter revenue reached $1.02 billion, matching estimates and increasing 7.1% year over year; the company also reported a substantial improvement in earnings compared with the prior-year quarter. Astrana Health third-quarter results
• Negative Sentiment: Reports said Astrana’s quarterly revenue guidance fell short of expectations. That weaker forward outlook may have outweighed the revenue growth and profit improvement in the reported quarter, pressuring the shares. Report on results and guidance

Institutional Trading of Astrana Health

Several large investors have recently modified their holdings of the company. Maryland State Retirement & Pension System lifted its stake in shares of Astrana Health by 50.7% in the 3rd quarter. Maryland State Retirement & Pension System now owns 9,303 shares of the company’s stock worth $331,000 after purchasing an additional 3,129 shares during the period. Penn Capital Management Company LLC grew its position in Astrana Health by 13.9% during the third quarter. Penn Capital Management Company LLC now owns 19,565 shares of the company’s stock valued at $696,000 after buying an additional 2,388 shares during the period. VIRGINIA RETIREMENT SYSTEMS ET Al grew its position in Astrana Health by 19.3% during the third quarter. VIRGINIA RETIREMENT SYSTEMS ET Al now owns 13,600 shares of the company’s stock valued at $484,000 after buying an additional 2,200 shares during the period. Simplicity Wealth LLC bought a new stake in Astrana Health during the third quarter valued at approximately $296,000. Finally, Sterling Capital Management LLC increased its holdings in Astrana Health by 17.2% during the third quarter. Sterling Capital Management LLC now owns 9,269 shares of the company’s stock valued at $330,000 after buying an additional 1,359 shares during the last quarter. Institutional investors own 52.77% of the company’s stock.

Astrana Health Stock Performance

Shares of NASDAQ:ASTH opened at $34.50 on Monday. The company has a market cap of $1.92 billion, a P/E ratio of 32.24 and a beta of 1.18. The company has a debt-to-equity ratio of 1.00, a current ratio of 1.25 and a quick ratio of 1.23. Astrana Health has a 1 year low of $18.08 and a 1 year high of $51.60. The stock’s fifty day moving average price is $36.98 and its 200-day moving average price is $34.02.

Astrana Health (NASDAQ:ASTH) last released its quarterly earnings data on Thursday, November 5th. The company reported $0.71 EPS for the quarter, topping the consensus estimate of $0.46 by $0.25. Astrana Health had a return on equity of 11.57% and a net margin of 1.36%. The company had revenue of $1.02 billion during the quarter, compared to the consensus estimate of $1.02 billion. During the same period last year, the company earned $0.01 EPS. Astrana Health’s revenue for the quarter was up 7.1% on a year-over-year basis. Sell-side analysts expect that Astrana Health will post 1.36 earnings per share for the current year.

About Astrana Health

Astrana Health, Inc (NASDAQ: ASTH), formerly known as Apollo Medical Holdings, is a healthcare enablement company focused on helping providers and health plans deliver coordinated, value-based care. The company combines physician networks, care-management capabilities, technology and data analytics to support improved clinical outcomes and more efficient healthcare delivery.

Astrana Health’s services include population health management, physician practice support, utilization management, care coordination and clinical analytics.